SCHEMBL18993636

SCHEMBL18993636

CCCCNc1cc(C(=O)O)cc(NCc2ccoc2)c1Oc1ccccc1

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 2/20 0.60
▸ BLM P54132 2/20 0.60
▸ CA2 P00918 2/20 0.60
▸ KDM4E B2RXH2 1/20 0.60
▸ USP2 O75604 1/20 0.60
▸ LMNA P02545 1/20 0.60
▸ HPGD P15428 1/20 0.60
▸ TSHR P16473 1/20 0.60
▸ SLC12A2 P55011 1/20 0.60
▸ HIF1A Q16665 1/20 0.60
▸ NPSR1 Q6W5P4 1/20 0.60
▸ HSD17B10 Q99714 1/20 0.60
▸ AQP1 P29972 1/20 0.45
▸ PTGS2 P35354 8/20 0.44
▸ HDAC3 O15379 1/20 0.39
▸ HDAC8 Q9BY41 1/20 0.39
▸ HCAR3 P49019 1/20 0.38
▸ FAAH O00519 2/20 0.38
▸ MAPT P10636 2/20 0.38
▸ MEN1 O00255 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18993702 0.93 ALDH1A1 (0.61) ALDH1A1BLMCA2KDM4EUSP2
SCHEMBL2741873 0.88 CA2 (0.68) ALDH1A1BLMCA2KDM4EUSP2
SCHEMBL13283807 0.87 ALDH1A1 (0.61) ALDH1A1BLMCA2KDM4EUSP2
SCHEMBL18993748 0.86 ALDH1A1 (0.46) ALDH1A1BLMCA2KDM4EUSP2
SCHEMBL19300067 0.83 ALDH1A1 (0.61) ALDH1A1BLMCA2KDM4EUSP2
SCHEMBL2741867 0.83 KDM4E (0.72) ALDH1A1BLMCA2KDM4EUSP2
SCHEMBL2741865 0.82 KDM4E (0.71) ALDH1A1BLMCA2KDM4EUSP2
SCHEMBL21018922 0.81 LMNA (0.50) ALDH1A1BLMCA2KDM4EUSP2
SCHEMBL18993700 0.81 ALDH1A1 (0.59) ALDH1A1BLMCA2KDM4EUSP2
SCHEMBL19300066 0.81 HPGD (0.61) ALDH1A1BLMCA2KDM4EUSP2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9682928-B2 Bumetanide analogs, compositions and methods of use NEUROPRO THERAPEUTICS, INC. (US) 2017-06-20 — — US disclosed
Send feedback